
New AAN Evidence in Focus Article Highlights Gene Therapy for Duchenne Muscular Dystrophy
The American Academy of Neurology (AAN) has recently published a new Evidence in Focus article that may be of particular interest to the TREAT-NMD network. The piece, titled “Delandistrogene Moxeparvovec [...]